speb/financial-data huggingface dataset:
INDOFARM.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 595963000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -295477000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 12656000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 12656000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 480516000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 480516000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 731704000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 731704000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 761824000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 761824000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Change In Inventory: -61592000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: -32293000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 11780000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Change In Payable: -11236000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -172187000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: -265528000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Changes In Cash: 135741000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Common Stock: 480516000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 480516000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 5564817000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 5564817000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 0.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Construction In Progress: 294478000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Construction In Progress: 294478000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 2592129000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 807545000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Current Assets: 4436683000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 4436683000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 3527000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 3527000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Current Debt: 1037672000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 1037672000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 1041199000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 1041199000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 1513589000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 1513589000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 16582000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 16582000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Depreciation: 122523000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 122523000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 122523000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 31794000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 122523000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 31794000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 48167956.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 1.81
INDOFARM.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 246935000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 87184000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Dividends Received Cfi: 59000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — EBIT: 523660000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — EBIT: 166146000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — EBITDA: 646183000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — EBITDA: 197940000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — End Cash Position: 731704000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: -413399000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: 1485000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -854000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -3078000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 88024000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 88024000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 2314632000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 2314632000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Gross Profit: 1808076000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 532383000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Interest Expense: 174552000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 42498000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 174552000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 42498000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -173097000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 53516000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Inventory: 1791247000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Inventory: 1791247000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 7047632000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 7047632000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: 252178000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 16637000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 16637000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 0.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 9129000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 9129000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 445143000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 445143000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 454272000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 454272000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 84840000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 84840000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 0.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Net Debt: 751111000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 751111000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Net Income: 246935000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Net Income: 87184000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 246935000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 87184000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 246934000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 87184000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 246935000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 87184000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 246935000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 87184000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 349108000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 246934000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 87184000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Net Interest Income: -174552000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -42498000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: 493382000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -236963000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -264809000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -174552000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -42498000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Net Other Investing Changes: -1000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Net PPE: 2314632000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 2314632000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -294778000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: 27846000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 5476793000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5476793000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 0.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 0.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 41008000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 41008000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 646183000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 197940000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Normalized Income: 246935000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 87184000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 296962000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Operating Income: 458244000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Operating Income: 154430000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Operating Revenue: 4400205000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 1339928000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 48051600.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 48051600.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 139850000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 139850000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 14967000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 14967000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 5084301000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 5084301000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: 121035000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 15368000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 15368000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 65415000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 11716000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 667849000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 188003000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Other Properties: 2020154000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 2020154000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Other Receivables: 543418000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Other Receivables: 543418000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 30120000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 30120000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Payables: 329098000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Payables: 329098000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Pension And Employee Benefit Expense: 24313000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Pretax Income: 349108000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 123648000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 8888000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -295477000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 2592129000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 807545000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 122523000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 31794000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 699000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Share Issued: 48051600.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 48051600.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 5564817000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 5564817000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 5476793000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5476793000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Tax Provision: 102174000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Tax Provision: 36464000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.29
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.29
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Taxes Receivable: 2673000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Taxes Receivable: 2673000.00
INDOFARM.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -59446000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Total Assets: 7703482000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 7703482000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 6009960000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 6009960000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Total Debt: 1495471000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 1495471000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 5564817000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 5564817000.00
INDOFARM.NS income_statement (annual, 2026-03-31) — Total Expenses: 3941961000.00
INDOFARM.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 1185498000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 2138665000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2138665000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 3266798000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 3266798000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 625076000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 625076000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 15406000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 15406000.00
INDOFARM.NS balance_sheet (annual, 2026-03-31) — Working Capital: 2923094000.00
INDOFARM.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 2923094000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — +Operating Expense: 5096700000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — +Total Revenue: 39061900000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Accounts Payable: 10241300000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Accounts Receivable: 1829800000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -4677600000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 4475900000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -566400000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Amortization: 1900000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 1900000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Available For Sale Securities: 44500000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Basic Average Shares: 261113151.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Basic EPS: 10.30
INDORAMA.NS cash_flow (annual, 2022-03-31) — Beginning Cash Position: 36900000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 1553500000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Capital Expenditure: -801600000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Capital Lease Obligations: 319100000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Capital Stock: 2611100000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Cash And Cash Equivalents: 35100000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Cash Cash Equivalents And Short Term Investments: 99200000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Cash Dividends Paid: -700000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 22500000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 35100000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Change In Inventory: -1401800000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Change In Other Current Assets: -628700000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Change In Other Current Liabilities: 76200000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Change In Payable: 1530900000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Change In Receivables: -777000000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Change In Working Capital: -1160500000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Changes In Cash: 20700000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Common Stock: 2611100000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Common Stock Equity: 6002100000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Construction In Progress: 716600000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Cost Of Revenue: 31193500000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Current Assets: 10386900000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Current Capital Lease Obligation: 57500000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Current Debt: 1486400000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Current Debt And Capital Lease Obligation: 1543900000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Current Liabilities: 12690800000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 432900000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Depreciation: 310700000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Depreciation And Amortization: 312600000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Depreciation And Amortization In Income Statement: 312600000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Depreciation Income Statement: 310700000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Diluted Average Shares: 261113151.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Diluted EPS: 10.30
INDORAMA.NS income_statement (annual, 2022-03-31) — Diluted NI Availto Com Stockholders: 2690600000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 1500000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — EBIT: 2683800000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — EBITDA: 2996400000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — End Cash Position: 57600000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Financing Cash Flow: -1226600000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 1722500000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Free Cash Flow: 1200100000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Gain Loss On Investment Securities: -400000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Gain Loss On Sale Of PPE: -100000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 188200000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Goodwill And Other Intangible Assets: 5600000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 2396200000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Gross PPE: 12410700000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Gross Profit: 7868400000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Impairment Of Capital Assets: 1700000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Interest Expense: 489400000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Interest Expense Non Operating: 489400000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Interest Income: 49400000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 49400000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Interest Paid Cff: -599200000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Interest Received Cfi: 46800000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Inventory: 5430700000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Invested Capital: 9218000000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Investing Cash Flow: -754400000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Investmentin Financial Assets: 0.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 387400000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 30500000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Long Term Capital Lease Obligation: 261600000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Long Term Debt: 1729500000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Long Term Debt And Capital Lease Obligation: 1991100000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 387400000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -736400000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Long Term Equity Investment: 0.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 369000000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 10110100000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Net Debt: 3180800000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Net Income: 2690600000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Net Income Common Stockholders: 2690600000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Net Income Continuous Operations: 2690600000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Net Income From Continuing And Discontinued Operation: 2690600000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Net Income From Continuing Operation Net Minority Interest: 2690600000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Net Income From Continuing Operations: 2194400000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Net Income Including Noncontrolling Interests: 2690600000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Net Interest Income: -569500000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Net Investment Purchase And Sale: 600000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -560900000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Net Long Term Debt Issuance: -349000000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Net Non Operating Interest Income Expense: -569500000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: -1900000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Net PPE: 7733100000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Net PPE Purchase And Sale: -799900000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: -211900000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Net Tangible Assets: 5996500000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Assets: 2586100000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Non Current Deferred Taxes Liabilities: 1600000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 338800000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Normalized EBITDA: 3039400000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Normalized Income: 2720700000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Operating Cash Flow: 2001700000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Operating Income: 2771700000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Operating Revenue: 39061900000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Ordinary Shares Number: 261113151.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Other Current Assets: 880000000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Other Current Liabilities: 5600000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Other Equity Interest: 3391000000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 5600000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Other Inventories: 42800000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Other Non Cash Items: 571200000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Other Non Current Assets: 624200000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Other Non Current Liabilities: 10300000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Other Non Operating Income Expenses: 11900000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Other Operating Expenses: 2900500000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Other Payable: 350200000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Other Properties: 7016500000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 2324800000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Other Short Term Investments: 64100000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Other Special Charges: -15400000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Payables: 10593200000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Pension And Employee Benefit Expense: -21000000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 678400000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Pretax Income: 2194400000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Purchase Of Investment: -1900000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Purchase Of PPE: -801600000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 3392500000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Reconciled Cost Of Revenue: 31193500000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Reconciled Depreciation: 312600000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 95900000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 95900000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -736400000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 24000000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: -1825000000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Sale Of Investment: 600000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Sale Of PPE: 1700000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 1580500000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 1768700000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Share Issued: 261113151.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Special Income Charges: -43400000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Stockholders Equity: 6002100000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Tangible Book Value: 5996500000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Tax Effect Of Unusual Items: -12900000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Tax Provision: -496200000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Tax Rate For Calcs: 0.30
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Taxes Receivable: 250500000.00
INDORAMA.NS cash_flow (annual, 2022-03-31) — Taxes Refund Paid: 27400000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Total Assets: 21054600000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Total Capitalization: 7731600000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Total Debt: 3535000000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Total Equity Gross Minority Interest: 6002100000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Total Expenses: 36290200000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Total Liabilities Net Minority Interest: 15052500000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Total Non Current Assets: 10667700000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Total Non Current Liabilities Net Minority Interest: 2361700000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 129500000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Total Tax Payable: 200000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Total Unusual Items: -43000000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Total Unusual Items Excluding Goodwill: -43000000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Work In Process: 272900000.00
INDORAMA.NS balance_sheet (annual, 2022-03-31) — Working Capital: -2303900000.00
INDORAMA.NS income_statement (annual, 2022-03-31) — Write Off: 57100000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — +Operating Expense: 5253200000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — +Total Revenue: 39073100000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 11077500000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 1621400000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -4736100000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 4475900000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -583300000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Amortization: 2400000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 2400000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 4100000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 261113151.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Basic EPS: -0.94
INDORAMA.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 57600000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 1522600000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -3652900000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 242500000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 2611100000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 560400000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 614000000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -700000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 560400000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -1005900000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -1262100000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -158500000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Change In Payable: 954800000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 191500000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -1234200000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 502800000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Common Stock: 2611100000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 5726600000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 3382200000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 33557700000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Current Assets: 12955800000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 21700000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Current Debt: 3055400000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 3077100000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 15158300000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 457400000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Depreciation: 311000000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 313400000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 313400000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 311000000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 261113151.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Diluted EPS: -0.94
INDORAMA.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: -245600000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 800000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — EBIT: 249100000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — EBITDA: 562500000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — End Cash Position: 560400000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 0.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 4788600000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 2813200000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: -4462800000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: 500000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: 22700000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 244500000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 3200000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 2204700000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 15945800000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Gross Profit: 5515400000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 0.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Interest Expense: 496300000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 496300000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Interest Income: 124500000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 124500000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -604700000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 124400000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Inventory: 6436600000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 14385400000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -3475900000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 4100000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 4575400000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 30500000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 220800000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt: 5603400000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 5824200000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 4575400000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -1081500000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 0.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 420400000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 11010500000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Net Debt: 8098400000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Net Income: -245600000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: -245600000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: -248800000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: -245600000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: -245600000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: -247200000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: -248800000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Net Interest Income: -471300000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: 0.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 5442900000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 3493900000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -471300000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Net Other Investing Changes: -4300000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Net PPE: 11209700000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -3596000000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 1949000000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 5723400000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 2586100000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 0.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 356300000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 575000000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Normalized Income: -236850000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: -809900000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Operating Income: 262200000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Operating Revenue: 39073100000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 261113151.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 1339800000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 400000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 3200000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 81600000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 353500000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: -14900000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 11700000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 3911000000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Other Payable: 406300000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Other Properties: 7827500000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 3040300000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 53600000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Other Special Charges: 11500000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Payables: 11484600000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 1242700000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Pretax Income: -247200000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -3652900000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 3300200000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 33557700000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 313400000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 162200000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 162200000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -1081500000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 800000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: -2070600000.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 0.00
INDORAMA.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 56900000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 964200000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 1208700000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Share Issued: 261113151.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Special Income Charges: -12500000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 5726600000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 5723400000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -3750000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Tax Provision: 1600000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.30
INDORAMA.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -36500000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Total Assets: 27129500000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 11330000000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Total Debt: 8901300000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 5726600000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Total Expenses: 38810900000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 21402900000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 14173700000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 6244600000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 99500000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 0.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -12500000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -12500000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Work In Process: 241600000.00
INDORAMA.NS balance_sheet (annual, 2023-03-31) — Working Capital: -2202500000.00
INDORAMA.NS income_statement (annual, 2023-03-31) — Write Off: 1000000.00
INDORAMA.NS income_statement (annual, 2024-03-31) — +Operating Expense: 4702600000.00
INDORAMA.NS income_statement (annual, 2024-03-31) — +Total Revenue: 36961000000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 10559300000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 1647300000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -5074300000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 4475900000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -583300000.00
INDORAMA.NS income_statement (annual, 2024-03-31) — Amortization: 2300000.00
INDORAMA.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 2300000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 3200000.00
INDORAMA.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 261113151.00
INDORAMA.NS income_statement (annual, 2024-03-31) — Basic EPS: -7.79
INDORAMA.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 560400000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 2830400000.00
INDORAMA.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -2601000000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 226500000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 2611100000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 236600000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 293700000.00
INDORAMA.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -800000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 0.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 236600000.00
INDORAMA.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 529800000.00
INDORAMA.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -672200000.00
INDORAMA.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 31400000.00
INDORAMA.NS cash_flow (annual, 2024-03-31) — Change In Payable: -510100000.00
INDORAMA.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -25900000.00
INDORAMA.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -623800000.00
INDORAMA.NS cash_flow (annual, 2024-03-31) — Changes In Cash: -323800000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Common Stock: 2611100000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 3681000000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 1125100000.00
INDORAMA.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 33013900000.00
INDORAMA.NS balance_sheet (annual, 2024-03-31) — Current Assets: 12785400000.00